Drug Markets/Tropicamide

Tropicamide

7 NDCs across 3 manufacturers|7 Generic,0 Brand

Tropicamide is used to treat iridocyclitis, iritis and keratitis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $10K on Tropicamide across 1,067 claims for 982 beneficiaries.

Tropicamide is available as 7 NDCs from 3 manufacturers (7 generic, 0 brand), with NADAC prices from $0.53 to $3.62 per MLthe most expensive product costs about 6.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

7

7G / 0B

Manufacturers

3

competing in market

Price Spread

$0.53 – $3.62

per ML

7d Activity

313 flat

avg +2.2% WoW · of 7 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

7 NDCs total, 7 shown

Frequently Asked Questions

What is Tropicamide used to treat?

Tropicamide is used to treat iridocyclitis, iritis and keratitis, per the National Library of Medicine's MED-RT classification.

When did Tropicamide become available as a generic?

FDA approved the first generic Tropicamide (ANDA) on Jan 1, 1982.

How much does Medicare spend on Tropicamide?

In 2024, Medicare Part D spent $10K on Tropicamide across 1,067 claims for 982 beneficiaries.

How many Tropicamide products are on the market?

The Tropicamide drug market contains 7 NDCs from 3 manufacturers — 7 generic and 0 brand products.

What is the price range for Tropicamide?

NADAC reference prices for Tropicamide range from $0.5349 to $3.6200 per ML — the most expensive product costs about 6.8× the cheapest.

Which manufacturers make Tropicamide?

3 manufacturers list Tropicamide in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (3), Sandoz Inc. (3), Somerset Therapeutics, LLC (1).

How has the price of Tropicamide changed recently?

Over the past 7 days, 3 Tropicamide NDCs rose and 1 fell, with a market-wide average change of +2.2%.